Baltimore, MD, United States of America

Pierre Thiebaud

This inventor holds 1 USPTO granted patent. Top assignee: Cranius LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pierre Thiebaud. Retrieved from https://idiyas.com/inventor/pierre-thiebaud-tizkb5zy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Pierre Thiebaud: Inventor of a Cranial Drug Delivery System

Introduction

Pierre Thiebaud is an inventor associated with Baltimore, Maryland. His work includes a patent for a cranial drug delivery system, and he is affiliated with Cranius LLC.

Latest Patents

Thiebaud is credited with 1 patent, titled “Cranial Drug Delivery System.” The invention describes a medical implant housing that can replace missing bone or soft tissue and deliver fluid to a target site through one or more catheters. Its design includes a two-phase propellant and a pump intended to maintain constant infusion pressure, along with a mechanical flow regulator designed to maintain a constant flow rate.

Career Highlights

A key highlight of Thiebaud’s inventive work is the development of an implant-based approach to controlled cranial drug delivery. The patent combines reconstructive implant functionality with mechanisms for regulating fluid pressure and flow.

Collaborations

Thiebaud is associated with Cranius LLC. His listed coworkers include Owen Friesen and Basile Michelet.

Conclusion

Pierre Thiebaud’s patented cranial drug delivery system brings together reconstructive implantation and controlled fluid delivery in a single medical device concept.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…